Location: Home
  • search
  • go
  • Relate News
  • 12/21/2020Astellas Enters Import and Commercialization Pact with Baheal for AML ...
  • 12/21/2020CDE Issues the Technical Guidelines for Clinical Research of Drugs for...
  • 12/21/2020Takeda to Divest Select Assets in China to Hasten Biopharma for $322M
  • 12/21/2020Global and China CRO Industry Report, 2020-2026 – M&As will Still Pre...
  • 12/21/2020Merck & Co. and HitGen in License Deal for Potential Development of a...
  • 12/21/2020Prevalence and Causes of Vision Loss in China from 1990 to 2019: Findi...
  • 12/18/2020Top Chinese Pharma Cos in Torreya's The Pharma 1000 in 2020
  • 12/18/2020CPA Hospital Drug Consumption Audit Reveals Elevated Consumption of NR...
  • 12/18/2020NMPA Reinstates Import of Supriya's Chlorphenamine Maleate API
  • 12/18/2020Recent Executive Moves
  • 12/17/2020CDE Issues the Technical Guidelines for Biological Effect Detection St...
  • 12/15/2020State Council Supports Commercial Health Insurance to Supplement the B...
  • 12/15/2020SMEI Forecasts Rise of Startups, Premium Generics, Self-paid Meds and ...
  • 12/15/2020Ping An Good Doctor and Tsumura (China) Enter into Strategic Cooperati...
  • 12/15/2020Shandong Kexing Bio Debuts IPO on Shanghai STAR Market
  • 12/15/2020Oncocyte and Burning Rock Execute Strategic Agreement to Distribute De...
  • 12/14/2020PharmaBlock Enters Strategic Partnership with Ascentage Pharma
  • 12/14/2020Global Investors Worried as China's Major Companies Default
  • 12/13/2020PharmaDJ: First Chinese Regulation for Customized Commercial Insurance...
  • 12/11/2020State Council Approves Draft Regulation on the Use of Medical Insuranc...
  • 12/10/2020NMPA Reinstates Import of LLM's Difrarel Tablets
  • 12/9/2020NHSA Sets Up Expert Bank for Regional Point-based Global Budgetary Man...
  • 12/9/2020Chi-Med Commences Construction of a Large-Scale Manufacturing Plant i...
  • 12/9/2020Immutep and EOC to Start Phase II Metastatic Breast Cancer Study
  • 12/8/2020Henlius Adalimumab Biosimilar Approved by NMPA
  • 12/8/2020JD Health Jumps 56% in Hong Kong Debut
  • 12/8/2020UCB Gains Chinese Approval for New Indication of KEPPRA (Levetiracetam...
  • 12/8/2020Ascentage Announces Positive Data from Pivotal Phase II Studies of HQP...
  • 12/7/2020Amgen Launches Prolia (Denosumab Injection) in China
  • 12/7/2020Sinovac Gets $515M Investment from Sino Biopharma to Double Covid-19 V...
  • Page:116/372 Total number of articles:11144: [First][<<] [114] [115] [116] [117] [118] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group